WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to ...
Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics ...
Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.
The FDA is advising restaurants and retailers to not serve or sell certain raw oysters due to a possible norovirus contamination.
WASHINGTON — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win ...
Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...
NG Biotech, in partnership with Hardy Diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designations to two rapid diagnostic assays: ...
InvestorsHub on MSN
Spruce Biosciences reports positive FDA meetings as it prepares TA-ERT filing for rare pediatric disorder
Spruce Biosciences, Inc. (NASDAQ:SPRB) said it has completed two Type B meetings with the U.S. Food and Drug Administration (FDA), clearing key regulatory discussions ahead of its planned biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results